Compare SHASUN PHARMA with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs SUVEN LIFESCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA SUVEN LIFESCIENCES SHASUN PHARMA/
SUVEN LIFESCIENCES
 
P/E (TTM) x 123.9 19.4 639.8% View Chart
P/BV x 8.5 3.9 217.4% View Chart
Dividend Yield % 0.2 0.5 43.4%  

Financials

 SHASUN PHARMA   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
SUVEN LIFESCIENCES
Mar-19
SHASUN PHARMA/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs94338 27.9%   
Low Rs46169 26.9%   
Sales per share (Unadj.) Rs214.252.1 410.9%  
Earnings per share (Unadj.) Rs5.36.8 78.1%  
Cash flow per share (Unadj.) Rs15.88.6 184.6%  
Dividends per share (Unadj.) Rs1.001.50 66.7%  
Dividend yield (eoy) %1.40.6 241.8%  
Book value per share (Unadj.) Rs53.365.3 81.7%  
Shares outstanding (eoy) m56.62127.28 44.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.9 6.7%   
Avg P/E ratio x13.137.1 35.3%  
P/CF ratio (eoy) x4.429.6 14.9%  
Price / Book Value ratio x1.33.9 33.7%  
Dividend payout %18.722.0 85.3%   
Avg Mkt Cap Rs m3,95832,272 12.3%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m2,164661 327.2%   
Avg. sales/employee Rs ThNM6,132.2-  
Avg. wages/employee Rs ThNM611.1-  
Avg. net profit/employee Rs ThNM803.5-  
INCOME DATA
Net Sales Rs m12,1276,635 182.8%  
Other income Rs m229242 94.7%   
Total revenues Rs m12,3566,877 179.7%   
Gross profit Rs m1,0091,604 62.9%  
Depreciation Rs m594221 268.1%   
Interest Rs m41538 1,101.1%   
Profit before tax Rs m2301,587 14.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73718 -10.1%   
Profit after tax Rs m302869 34.8%  
Gross profit margin %8.324.2 34.4%  
Effective tax rate %-31.745.2 -70.0%   
Net profit margin %2.513.1 19.0%  
BALANCE SHEET DATA
Current assets Rs m6,8846,232 110.5%   
Current liabilities Rs m8,4561,490 567.5%   
Net working cap to sales %-13.071.5 -18.1%  
Current ratio x0.84.2 19.5%  
Inventory Days Days6286 71.3%  
Debtors Days Days10883 130.2%  
Net fixed assets Rs m4,9704,043 122.9%   
Share capital Rs m113127 89.0%   
"Free" reserves Rs m2,8758,183 35.1%   
Net worth Rs m3,0208,310 36.3%   
Long term debt Rs m1,81718 10,210.1%   
Total assets Rs m13,34710,389 128.5%  
Interest coverage x1.643.1 3.6%   
Debt to equity ratio x0.60 28,092.5%  
Sales to assets ratio x0.90.6 142.3%   
Return on assets %5.48.7 61.5%  
Return on equity %10.010.5 95.6%  
Return on capital %13.319.5 68.3%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,8435,622 103.9%   
Fx outflow Rs m2,1731,799 120.8%   
Net fx Rs m3,6693,822 96.0%   
CASH FLOW
From Operations Rs m398356 111.8%  
From Investments Rs m-1,635-279 586.9%  
From Financial Activity Rs m1,309-225 -581.3%  
Net Cashflow Rs m71-148 -48.0%  

Share Holding

Indian Promoters % 39.2 63.4 61.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 0.0 -  
FIIs % 17.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 36.5 108.5%  
Shareholders   20,750 37,287 55.6%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   IPCA LABS  NOVARTIS  ALEMBIC PHARMA  PROCTER & GAMBLE HEALTH  SANOFI INDIA  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Economic Growth and Stock Markets: It's Not All Gloom and Doom(Podcast)

In addition to the usual stock market updates of the week, I talk about how RBI's monetary policy decision and slowing economy impacts you and your portfolio of stocks.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries?(Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

How We Made 12.68% in One Overnight Trade(The 5 Minute Wrapup)

Nov 25, 2019

This one trade had my subscribers laughing all the way to the bank.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Two Trends to Look at as Sensex Crosses 41,000 Levels(Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

The Best Trading Strategy for Fast Profits

Nov 29, 2019

Vijay and I have decided to team up and bring you a unique offering never seen before in the Indian stock markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS